Loading cancer entity…
Loading cancer entity…
Clinical trials
75 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (6)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02568267 | Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)(STARTRK-2) | active not recruiting | Phase 2 | 534 | Hoffmann-La RocheINDUSTRY | 16 | Aug 25, 2026 | clinicaltrials |
| NCT07226466 | Evaluating Biomarkers of Cognitive Dysfunction in Patients With Cancer | not yet recruiting | — | 40 | University of California, San FranciscoOTHER | 1 |
| Aug 18, 2026 |
| clinicaltrials |
| NCT04427384 | Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles) | recruiting | — | 600 | GT Medical Technologies, Inc.INDUSTRY | 1 | Jul 22, 2026 | clinicaltrials |
| NCT06185686 | Radiation Induced Alterations in Resting State Brain Networks in Pediatric Brain Tumor Patients | recruiting | — | 16 | Washington University School of MedicineOTHER | 1 | Jul 17, 2026 | clinicaltrials |
| NCT07688356 | Belvarafenib for CNS Efficacy in Patients With BRAF-Altered Solid Tumors | recruiting | Phase 2 | 30 | Samsung Medical CenterOTHER | 1 | Jul 8, 2026 | clinicaltrials |
| NCT06104488 | A Study of Avutometinib for People With Solid Tumor Cancers | active not recruiting | Phase 1 | 3 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 15, 2026 | clinicaltrials |
| NCT05576103 | Longitudinal Prospective Study of Neurocognition & Neuroimaging in Primary BT Patients | recruiting | — | 300 | Jona Hattangadi-GluthOTHER | 1 | Jun 10, 2026 | clinicaltrials |
| NCT03213002 | Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM(CAPTEM) | recruiting | Phase 1 / Phase 2 | 67 | Northwell HealthOTHER | 1 | Jun 1, 2026 | clinicaltrials |
| NCT03684109 | Non-invasive Glioma Characterization Through Molecular Imaging | recruiting | N/A | 30 | University of MiamiOTHER | 1 | Apr 20, 2026 | clinicaltrials |
| NCT07426848 | OT SMILE: Occupational Therapy Group Intervention for Primary Brain Tumour Patients(OTSMILE) | recruiting | N/A | 96 | Royal College of Surgeons, IrelandOTHER | 1 | Feb 23, 2026 | clinicaltrials |
| NCT06057168 | Performance of Elucirem in DSC-MRI Perfusion of Brain Gliomas(GDX-44-016) | completed | Phase 3 | 138 | GuerbetINDUSTRY | 3 | Jan 29, 2026 | clinicaltrials |
| NCT07085494 | Neurofeedback and Cognitive Training for PBTS | enrolling by invitation | N/A | 50 | The University of Hong KongOTHER | 1 | Jan 27, 2026 | clinicaltrials |
| NCT03262636 | Two-Part Study to Evaluate the Safety and Efficacy of Image Guided Surgery Using Indocyanine Green for Intramolecular Imaging of Nervous System Tumors Compared to Standard of Care, (TumorGlow)(TumorGlow(TM)) | completed | Phase 1 | 363 | University of PennsylvaniaOTHER | 0 | Jan 23, 2026 | clinicaltrials |
| NCT01535430 | Assessment of Eloquent Function in Brain Tumor Patients | recruiting | — | 75 | University of NebraskaOTHER | 1 | Jan 13, 2026 | clinicaltrials |
| NCT05106296 | Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer | recruiting | Phase 1 | 37 | Theodore S. JohnsonOTHER | 1 | Jan 9, 2026 | clinicaltrials |
| NCT06322342 | Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent | completed | Phase 2 | 18 | Reveal Pharmaceuticals Inc.INDUSTRY | 1 | Dec 26, 2025 | clinicaltrials |
| NCT07264023 | Correlation Between Nutritional Status of Childhood Neurological Tumors and Quality of Life | not yet recruiting | — | 93 | Nanfang Hospital, Southern Medical UniversityOTHER | 0 | Dec 16, 2025 | clinicaltrials |
| NCT06930846 | HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in Brain CAncer)(HOBSCOTCH-CA) | recruiting | N/A | 125 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Nov 21, 2025 | clinicaltrials |
| NCT05480644 | Circulating Biomarkers Repository in Adults Diagnosed With Primary and Metastatic Brain Tumors | recruiting | — | 300 | Duke UniversityOTHER | 1 | Nov 19, 2025 | clinicaltrials |
| NCT06439420 | CBT-I in Primary Brain Tumor Patients: Phase IIc Randomized Feasibility Pilot Trial(CBT-I in PBT) | completed | Phase 2 | 70 | Virginia Commonwealth UniversityOTHER | 1 | Oct 1, 2025 | clinicaltrials |
| NCT05634707 | Evaluation of Fluoxetine and Cytotoxic Lysosomal Stress in Glioma (FLIRT) | active not recruiting | Early Phase 1 | 10 | Duke UniversityOTHER | 1 | Sep 22, 2025 | clinicaltrials |
| NCT07179328 | Focused Ultrasound Blood-Brain Barrier Disruption for the Treatment of High-Grade Glioma in Patients Undergoing Standard Chemotherapy | recruiting | Phase 1 | 10 | Sunnybrook Health Sciences CentreOTHER | 1 | Sep 17, 2025 | clinicaltrials |
| NCT06831461 | Proton Versus Photon Radiotherapy in Adults With Primary Brain Tumors(PRIDE) | recruiting | N/A | 156 | Tata Memorial CentreOTHER | 1 | Sep 16, 2025 | clinicaltrials |
| NCT07036783 | 3D Decision Support Tool for Brain Tumour Surgery Development and Validation: Observational Study(STRATUM-OS) | not yet recruiting | — | 320 | Fundación Canaria Instituto de Investigación Sanitaria de CanariasOTHER | 0 | Jun 25, 2025 | clinicaltrials |
| NCT05775458 | Glutamate Excitotoxicity and Its Role in Glioblastoma Biology | recruiting | — | 50 | IRCCS San RaffaeleOTHER | 1 | Jun 11, 2025 | clinicaltrials |
| NCT05831631 | Characterization of Circulating and Tumor-infiltrating Immune Cells in Malignant Brain Tumors | recruiting | — | 200 | Pietro Mortini, MD, Prof.OTHER | 1 | Jun 11, 2025 | clinicaltrials |
| NCT04567251 | Survivorship Study of Cancer Patients Who Received Cranial Radiation Therapy(SPiRiT) | terminated | — | 5 | Duke UniversityOTHER | 1 | May 14, 2025 | clinicaltrials |
| NCT00639262 | Combination of Sorafenib and Radiation for Brain Metastases and Primary Brain Tumors | completed | Phase 1 | 35 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER | 1 | May 2, 2025 | clinicaltrials |
| NCT02392078 | Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System(LAANTERN) | completed | — | 1,153 | Monteris MedicalINDUSTRY | 1 | Apr 24, 2025 | clinicaltrials |
| NCT06929819 | Research on the Safety and Efficacy of Intraoperative Radiation Therapy in Malignant Cerebral Tumor | not yet recruiting | N/A | 200 | First Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 0 | Apr 16, 2025 | clinicaltrials |
| NCT06282562 | FeelFit: High-intensity Interval Training to Improve Self-reported Physical Fitness in Brain Tumor Patients(FeelFit) | recruiting | N/A | 36 | Amsterdam UMC, location VUmcOTHER | 1 | Apr 6, 2025 | clinicaltrials |
| NCT04066465 | Neurocognitive Function After Proton Therapy in Children and Adolescents(ELBE-ProKids) | recruiting | — | 90 | Technische Universität DresdenOTHER | 1 | Feb 6, 2025 | clinicaltrials |
| NCT05254197 | SeOuL cOhort of Brain Tumor MONitoring Study (SOLOMON)(SOLOMON) | recruiting | — | 3,000 | Seoul National University HospitalOTHER | 1 | Dec 3, 2024 | clinicaltrials |
| NCT01472731 | Safety and Imaging Study of GC1008 in Glioma | completed | Phase 2 | 12 | University Medical Center GroningenOTHER | 1 | May 6, 2024 | clinicaltrials |
| NCT05539677 | Biobank and Register of Patients With Agresive Tumors for Translational and Analytical Research(REGATA) | recruiting | — | 1,000 | N.N. Petrov National Medical Research Center of OncologyOTHER | 1 | May 6, 2024 | clinicaltrials |
| NCT02389855 | Laser Ablation in Stereotactic Neurosurgery (LAISE): NeuroBlate® Retrospective Registry | completed | — | 144 | Monteris MedicalINDUSTRY | 1 | Apr 12, 2024 | clinicaltrials |
| NCT04901806 | Study of PBI-200 in Subjects With NTRK-Fusion-Positive Solid Tumors | terminated | Phase 1 | 29 | Pyramid BiosciencesINDUSTRY | 11 | Mar 28, 2024 | clinicaltrials |
| NCT02338037 | Neuropharmacokinetics of Eribulin Mesylate in Treating Patients With Primary or Metastatic Brain Tumors | completed | Early Phase 1 | 8 | City of Hope Medical CenterOTHER | 1 | Mar 19, 2024 | clinicaltrials |
| NCT05660499 | Impact of the Development of Pediatric Palliative Care(PTB) | unknown | — | 40 | University Hospital, Strasbourg, FranceOTHER | 1 | Dec 14, 2023 | clinicaltrials |
| NCT03970499 | Ultrasound Elastography and Ultrasentive Doppler for Surgery of Brain Tumors(ELASTOGLI) | completed | N/A | 20 | University Hospital, ToursOTHER | 1 | Dec 5, 2023 | clinicaltrials |
| NCT06106997 | Clinical Feasibility of Brain Radiotherapy Using Synthetic CTs in an MRI-only Workflow | unknown | N/A | 54 | University of Erlangen-Nürnberg Medical SchoolOTHER | 1 | Oct 30, 2023 | clinicaltrials |
| NCT05739500 | MRI-based Computer Aided Diagnosis Software (V1) for Glioma | unknown | — | 250 | Mingge LLCINDUSTRY | 1 | Feb 22, 2023 | clinicaltrials |
| NCT04075370 | Exploring Compensation to Maintain Cognitive Function in Adults Newly Diagnosed With Brain Cancer | completed | — | 33 | Duke UniversityOTHER | 1 | Jan 20, 2023 | clinicaltrials |
| NCT04831190 | A Tailored Exercise Oncology Program for Neuro-Oncology Patients(ACE-Neuro) | unknown | N/A | 70 | University of CalgaryOTHER | 1 | Jan 18, 2023 | clinicaltrials |
| NCT01528046 | Metformin in Children With Relapsed or Refractory Solid Tumors | completed | Phase 1 | 26 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Jan 13, 2023 | clinicaltrials |
| NCT04919993 | CBT for Insomnia in Primary Brain Tumor Patients | completed | N/A | 44 | Virginia Commonwealth UniversityOTHER | 1 | Jan 13, 2023 | clinicaltrials |
| NCT04776980 | Multimodality MRI and Liquid Biopsy in GBM | withdrawn | Early Phase 1 | 0 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Sep 16, 2022 | clinicaltrials |
| NCT05092802 | The Efficacy of HLX208 (BRAF V600E Inhibitor) for Refractory Primary Brain Tumors With BRAF Mutation After First-line Treatment | unknown | Phase 2 | 40 | Shanghai Henlius BiotechINDUSTRY | 1 | May 3, 2022 | clinicaltrials |
| NCT05328739 | The Effect of Home Care Planned According to Orem in Patients With Primary Brain Tumor and Their Caregivers | completed | N/A | 36 | TC Erciyes UniversityOTHER | 1 | Apr 14, 2022 | clinicaltrials |
| NCT04306432 | Cognitive Function After Radiation Therapy for Primary Brain Tumours | recruiting | — | 300 | University of AarhusOTHER | 1 | Dec 2, 2021 | clinicaltrials |
Data updated 22 days agoSource updated Aug 25, 2026source: clinicaltrials